Identifying therapeutic targets for schizophrenia

Identifying therapeutic targets for schizophrenia

There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover...

Full description

Bibliographic Details
Main Author: Karli Montague-Cardoso
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-021-02270-3
id doaj-e8c68a00f79b4d2a84f00ab418323797
record_format Article
spelling doaj-e8c68a00f79b4d2a84f00ab4183237972021-06-13T11:33:25ZengNature Publishing GroupCommunications Biology2399-36422021-06-01411110.1038/s42003-021-02270-3Identifying therapeutic targets for schizophreniaKarli Montague-Cardoso0Communications BiologyThere is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover the precise pathomechanism. Their study sheds further light on the role of mTOR in Schizophrenia and could inform the development of future therapeutic strategies for the condition.https://doi.org/10.1038/s42003-021-02270-3
collection DOAJ
language English
format Article
sources DOAJ
author Karli Montague-Cardoso
spellingShingle Karli Montague-Cardoso
Identifying therapeutic targets for schizophrenia
Communications Biology
author_facet Karli Montague-Cardoso
author_sort Karli Montague-Cardoso
title Identifying therapeutic targets for schizophrenia
title_short Identifying therapeutic targets for schizophrenia
title_full Identifying therapeutic targets for schizophrenia
title_fullStr Identifying therapeutic targets for schizophrenia
title_full_unstemmed Identifying therapeutic targets for schizophrenia
title_sort identifying therapeutic targets for schizophrenia
publisher Nature Publishing Group
series Communications Biology
issn 2399-3642
publishDate 2021-06-01
description There is a continual need to develop new therapies for neuropsychiatric disorders such as Schizophrenia, and identifying the underlying molecular processes remains challenging. Chadha et al. recently discovered a potential role for mTOR kinase activity disruption in Schizophrenia and further uncover the precise pathomechanism. Their study sheds further light on the role of mTOR in Schizophrenia and could inform the development of future therapeutic strategies for the condition.
url https://doi.org/10.1038/s42003-021-02270-3
work_keys_str_mv AT karlimontaguecardoso identifyingtherapeutictargetsforschizophrenia
_version_ 1721379743653167104

Similar Items